Roche Vows To Appeal $12.9M Accutane Verdict
Hoffmann-La Roche has vowed to appeal after three plaintiffs who claimed they developed inflammatory bowel disease after taking the acne drug Accutane were awarded almost $13 million by a New Jersey...To view the full article, register now.
Already a subscriber? Click here to view full article